At a glance
ClinicalIndex Comparison RecordN/ACompleted· 250 enrolled
Drug / intervention
DSC +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prospective, Multi-center, Randomized Controlled Study Comparing Endoscopic Clearance of Non-Complex Biliary Stones Using Fluoroscopy/Radiation-Free Direct Solitary Cholangioscopy (DSC) to Standard of Care Endoscopic Retrograde Cholangiography (ERC)
In Brief
A clinical study evaluating DSC and ERC for Biliary Stones. Completed, enrolled 250 participants across 8 sites in 4 countries.
Detailed Summary
To prospectively compare non-complex biliary stone clearance using fluoroscopy/radiation-free direct solitary cholangioscopy (DSC) utilizing the SpyGlass™ system with non-complex biliary stone clearance using standard endoscopic retrograde cholangiography (ERC).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBiliary Stones
CountriesIndia, Italy, Thailand, United States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedFeb 2018
Enrollment StartSep 2018
Primary CompletionSep 2023
Study CompletionOct 2023
TodayJul 2026
First PostedFeb 5, 2018
Enrollment StartSep 21, 2018
Primary CompletionSep 18, 2023
Study CompletionOct 8, 2023
TodayJul 2, 2026
Enrollment to primary: 5.0 yearsPosted 8.4 years ago
Interventions
DSCdevice
Stone removal without fluoroscopy using the SpyGlass device.
ERCdevice
Standard of care stone removal with fluoroscopy.